288 related articles for article (PubMed ID: 12402138)
1. [Thalidomide therapy of cutaneous lupus erythematosus].
Bohmeyer J; Achenbach A; Westenberger M; Stadler R
Hautarzt; 2002 Nov; 53(11):744-8. PubMed ID: 12402138
[TBL] [Abstract][Full Text] [Related]
2. Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens.
Cuadrado MJ; Karim Y; Sanna G; Smith E; Khamashta MA; Hughes GR
Am J Med; 2005 Mar; 118(3):246-50. PubMed ID: 15745722
[TBL] [Abstract][Full Text] [Related]
3. [Thalidomide and thrombosis].
Flageul B; Wallach D; Cavelier-Balloy B; Bachelez H; Carsuzaa F; Dubertret L
Ann Dermatol Venereol; 2000 Feb; 127(2):171-4. PubMed ID: 10739975
[TBL] [Abstract][Full Text] [Related]
4. Low-dose thalidomide is an effective second-line treatment in cutaneous lupus erythematosus.
Thomson KF; Goodfield MJ
J Dermatolog Treat; 2001 Sep; 12(3):145-7. PubMed ID: 12243705
[TBL] [Abstract][Full Text] [Related]
5. [Thalidomide therapy for discoid lupus erythematosus].
Lyakhovisky A; Baum S; Shpiro D; Salomon M; Trau H
Harefuah; 2006 Jul; 145(7):489-92, 551. PubMed ID: 16900736
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide treatment for hypertrophic cutaneous lupus erythematosus.
Gambini D; Carrera C; Passoni E; Muratori S; Berti E; Caputo R
J Dermatolog Treat; 2004 Dec; 15(6):365-71. PubMed ID: 15764048
[TBL] [Abstract][Full Text] [Related]
7. Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy.
Ordi-Ros J; Cortés F; Cucurull E; Mauri M; Buján S; Vilardell M
J Rheumatol; 2000 Jun; 27(6):1429-33. PubMed ID: 10852265
[TBL] [Abstract][Full Text] [Related]
8. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.
Lampropoulos CE; Sangle S; Harrison P; Hughes GR; D'Cruz DP
Rheumatology (Oxford); 2004 Nov; 43(11):1383-5. PubMed ID: 15266063
[TBL] [Abstract][Full Text] [Related]
9. [Refractory subacute cutaneous lupus erythematosus treated with rituximab].
Cieza-Díaz DE; Avilés-Izquierdo JA; Ceballos-Rodríguez C; Suárez-Fernández R
Actas Dermosifiliogr; 2012; 103(6):555-7. PubMed ID: 22482740
[No Abstract] [Full Text] [Related]
10. Acute myocardial infarction in a patient with cutaneous lupus erythematosus treated with thalidomide.
Llambrich A; Romero D; Iranzo P; Segura S; Moreno JA; Herrero C
J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):136-7. PubMed ID: 17207199
[No Abstract] [Full Text] [Related]
11. A case series of 48 patients treated with thalidomide.
Doherty SD; Hsu S
J Drugs Dermatol; 2008 Aug; 7(8):769-73. PubMed ID: 18720694
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients.
Wenzel J; Brähler S; Bauer R; Bieber T; Tüting T
Br J Dermatol; 2005 Jul; 153(1):157-62. PubMed ID: 16029342
[TBL] [Abstract][Full Text] [Related]
13. Thalidomide in the treatment of refractory cutaneous lupus erythematosus: prognostic factors of clinical outcome.
Cortés-Hernández J; Torres-Salido M; Castro-Marrero J; Vilardell-Tarres M; Ordi-Ros J
Br J Dermatol; 2012 Mar; 166(3):616-23. PubMed ID: 21999437
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporin combined with methotrexate in two patients with recalcitrant subacute cutaneous lupus erythematosus.
Klein A; Vogt T; Wenzel SM; Fleck M; Landthaler M
Australas J Dermatol; 2011 Feb; 52(1):43-7. PubMed ID: 21332692
[TBL] [Abstract][Full Text] [Related]
15. Chronic cutaneous lupus erythematosus. Thalidomide treatment of 11 patients.
Hasper MF
Arch Dermatol; 1983 Oct; 119(10):812-5. PubMed ID: 6614949
[TBL] [Abstract][Full Text] [Related]
16. Leflunomide in subacute cutaneous lupus erythematosus - two sides of a coin.
Suess A; Sticherling M
Int J Dermatol; 2008 Jan; 47(1):83-6. PubMed ID: 18173611
[TBL] [Abstract][Full Text] [Related]
17. Positive and negative effects of thalidomide on refractory cutaneous lupus erythematosus.
Briani C; Zara G; Rondinone R; Iaccarino L; Ruggero S; Toffanin E; Ermani M; Ghirardello A; Zampieri S; Sarzi-Puttini P; Doria A
Autoimmunity; 2005 Nov; 38(7):549-55. PubMed ID: 16373260
[TBL] [Abstract][Full Text] [Related]
18. Efficiency of acitretin in the treatment of cutaneous lupus erythematosus.
Ruzicka T; Meurer M; Bieber T
Arch Dermatol; 1988 Jun; 124(6):897-902. PubMed ID: 2967674
[TBL] [Abstract][Full Text] [Related]
19. Pimecrolimus 1% cream for cutaneous lupus erythematosus.
Kreuter A; Gambichler T; Breuckmann F; Pawlak FM; Stücker M; Bader A; Altmeyer P; Freitag M
J Am Acad Dermatol; 2004 Sep; 51(3):407-10. PubMed ID: 15337984
[TBL] [Abstract][Full Text] [Related]
20. [Classification of dermatologic manifestations in lupus erythematosus].
Francès C; Barete S; Ayoub N; Piette JC
Ann Med Interne (Paris); 2003 Feb; 154(1):33-44. PubMed ID: 12746657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
